Med-IQ CME: Addressing Increased Detection, Early Rhythm Control, and the Role of AADs in Contemporary AF Management

Key Features

• The early detection and diagnosis of atrial fibrillation (AF) is key and can be facilitated by the use of wearable devices.
  
• Early rhythm control is associated with reduced AF symptoms, AF burden, and adverse cardiovascular (CV) outcomes.
  
• Treatment options for rhythm control include antiarrhythmic drugs (AADs) and catheter ablation (CA).
  
• Shared decision-making with the patient is necessary to optimize treatment selection for rhythm control.

Topics Covered

Wearable devices in the timely identification of AF, efficacy/safety of early rhythm control strategies, and the importance of shared decision making.

Learning Objectives

Upon completion, participants should be able to:

Physicians

• Outline the contributions and limitations of wearable devices in the detection of AF
  
• Describe clinical trial and real-world data on the efficacy and safety of AADs used in the management of new-onset AF
  
• Apply guideline recommendations and emerging evidence to decisions about the use of AADs for patients with new-onset AF that consider AF classification, clinical features, and patient factors
  
• Use established frameworks to guide patients with AF in shared decision-making conversations about early rhythm control and risk factor reduction strategies
  Pharmacists
  
• Outline the benefits and limitations of wearable devices in the detection of AF
  
• Identify the impact of early rhythm control on AF burden, disease progression, patient outcomes, and quality of life
  
• Review clinical trial and real-world data on the efficacy and safety of AADs used in the management of new-onset AF
  
• Use established frameworks to guide patients with AF in shared decision-making conversations about early rhythm control and risk factor reduction strategies

  Nurses
  

• Outline the benefits and limitations of wearable devices in the detection of AF
  
• Identify the impact of early rhythm control on AF burden, disease progression, patient outcomes, and quality of life
  
• Review clinical trial and real-world data on the efficacy and safety of AADs used in the management of new-onset AF
  
• Use established frameworks to guide patients with AF in shared decision-making conversations about early rhythm control and risk factor reduction strategies

Target Audience

This activity is intended for cardiologists, electrophysiologists, nurses, pharmacists, and other clinicians who care for people with AF.

Additional credit info

Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Med-IQ designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity enables the learner to earn credit toward the CME requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

To have your AMA PRA Category 1 Credits™ automatically reported to the ACCME PARS system, you will need to opt in to the data transmission process when prompted. Completion credits for physicians are transmitted by the ACCME to select state and medical specialty boards and are accessible through your CME Passport account. You will be required to provide your legal name (as it appears on your license), license state, month and day of birth, NPI, and specialty medical board ID number. Incorrect data may prohibit transmission. Click here for additional information. Inquiries can be submitted to [email protected].

Med-IQ is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

This nursing activity offers a maximum of 1.0 contact hour.

Med-IQ is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hour (0.10 CEU) of credit for pharmacists. ACPE #0476-0000-26-004-H01-P. This application-based activity is designed for all pharmacists.